Eriocitrin, a dietary flavonoid suppressed cell proliferation, induced apoptosis through modulation of JAK2/STAT3 and JNK/p38 MAPKs signaling pathway in MCF‐7 cells. Issue 1 (1st November 2021)

• Record Type: Journal Article
• Authors: Yuan, Chengliang; Chen, Guoping; Jing, Chengbao; Liu, Mengxue; Liang, Bo; Gong, Guojin; Yu, Mei
• Is Part Of: Journal of biochemical and molecular toxicology. Volume 36:Issue 1(2022)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2021-11-01
• Subjects: apoptosis -- cell proliferation -- Eriocitrin -- oxidative stress -- STAT3/MAPKs; Biochemistry -- Periodicals; Molecular biology -- Periodicals; Toxicology -- Periodicals; 574
• DOI: 10.1002/jbt.22943
• Languages: English
• ISSNs: 1095-6670

Abstract

Abstract: Eriocitrin, a lemons flavanone, exhibits several biological properties, antiproliferative, and proapoptotic effects. However, its molecular mechanical action is not entirely clarified. Oxidative stress causes abnormal stimulation of signal transducer and activator of transcription 3 (STAT3) and c‐Jun NH2‐terminal kinase (JNK), p38 mitogen‐activated protein kinases (MAPKs) signaling has been strongly connected with the ruling of cell survival and apoptosis of cancer cells. Herein, we investigated an antiproliferative and proapoptotic effect that Eriocitrin modulates STAT3/MAPKs signaling activation in MCF‐7 cells. We noticed that Eriocitrin strongly enhances reactive oxygen species (ROS) generation, alteration of mitochondrial outer membrane potential, and enhances apoptotic morphological changes. Furthermore, Eriocitrin suppressed STAT3 phosphorylation via inhibiting an upstream molecule of JAK2 and Src kinase activation, thereby blocking STAT3 nuclear translocation. Similarly, Eriocitrin causes oxidative stress‐mediated JNK/p38 MAPK signaling activation. We confirmed that Eriocitrin induced ROS‐mediated apoptosis inhibited by the antioxidant substance of N‐acetylcysteine. Eriocitrin induced apoptosis via suppression of STAT3 signaling regulated proteins, activating proapoptotic factors Bax, caspase 7, 8, 9 and suppressing Bcl‐2, Bcl‐x expression in MCF‐7 cells. Overall, these results evidenced that Eriocitrin can affect multiple signaling events associated with tumorigenesis. From this evidence, Eriocitrin, a novel chemotherapeutic agent, can be used to treat breast cancer.